Yu Jiayang, Wang Chun-Guang
Department of Oncology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Front Oncol. 2023 Jan 24;13:1047336. doi: 10.3389/fonc.2023.1047336. eCollection 2023.
Genetic variability in DNA double-strand break repair genes such as RAD51 gene and its paralogs XRCC2、XRCC3 may contribute to the occurrence and progression of breast cancer. To obtain a complete evaluation of the above association, we performed a meta-analysis of published studies.
Electronic databases, including PubMed, EMBASE, Web of Science, and Cochrane Library, were comprehensively searched from inception to September 2022. The Newcastle-Ottawa Scale (NOS) checklist was used to assess all included non-randomized studies. Odds ratios (OR) with 95% confidence intervals (CI) were calculated by STATA 16.0 to assess the strength of the association between single nucleotide polymorphisms (SNPs) in these genes and breast cancer risk. Subsequently, the heterogeneity between studies, sensitivity, and publication bias were performed. We downloaded data from The Cancer Genome Atlas (TCGA) and used univariate and multivariate Cox proportional hazard regression (CPH) models to validate the prognostic value of these related genes in the R software.
The combined results showed that there was a significant correlation between the G172T polymorphism and the susceptibility to breast cancer in the homozygote model (OR= 1.841, 95% CI=1.06-3.21, =0.03). Furthermore, ethnic analysis showed that SNP was associated with the risk of breast cancer in Arab populations in homozygous models (OR=3.52, 95% CI=1.13-11.0, = 0.003). For the XRCC2 R188H polymorphism, no significant association was observed. Regarding polymorphism in XRCC3 T241M, a significantly increased cancer risk was only observed in the allelic genetic model (OR=1.05, 95% CI= 1.00-1.11, =0.04).
In conclusion, this meta-analysis suggests that Rad51 G172T polymorphism is likely associated with an increased risk of breast cancer, significantly in the Arab population. The relationship between the XRCC2 R188H polymorphism and breast cancer was not obvious. And T241M in XRCC3 may be associated with breast cancer risk, especially in the Asian population.
DNA双链断裂修复基因(如RAD51基因及其旁系同源基因XRCC2、XRCC3)的遗传变异性可能与乳腺癌的发生和发展有关。为了全面评估上述关联,我们对已发表的研究进行了荟萃分析。
全面检索了包括PubMed、EMBASE、Web of Science和Cochrane图书馆在内的电子数据库,检索时间从数据库创建至2022年9月。使用纽卡斯尔-渥太华量表(NOS)清单评估所有纳入的非随机研究。通过STATA 16.0计算比值比(OR)及其95%置信区间(CI),以评估这些基因中的单核苷酸多态性(SNP)与乳腺癌风险之间关联的强度。随后,进行了研究间的异质性、敏感性和发表偏倚分析。我们从癌症基因组图谱(TCGA)下载数据,并在R软件中使用单变量和多变量Cox比例风险回归(CPH)模型来验证这些相关基因的预后价值。
综合结果显示,在纯合子模型中,G172T多态性与乳腺癌易感性之间存在显著相关性(OR = 1.841,95%CI = 1.06 - 3.21,P = 0.03)。此外,种族分析表明,在纯合子模型中,SNP与阿拉伯人群的乳腺癌风险相关(OR = 3.52,95%CI = 1.13 - 11.0,P = 0.003)。对于XRCC2 R188H多态性,未观察到显著关联。关于XRCC3 T241M多态性,仅在等位基因遗传模型中观察到癌症风险显著增加(OR = 1.05,95%CI = 1.00 - 1.11,P = 0.04)。
总之,这项荟萃分析表明,Rad51 G172T多态性可能与乳腺癌风险增加有关,在阿拉伯人群中尤为显著。XRCC2 R188H多态性与乳腺癌之间的关系不明显。XRCC3中的T241M可能与乳腺癌风险相关,尤其是在亚洲人群中。